Company: SXTPW
Filing Date: 2025-03-27
Form Type: 10-K
Source: 0001013762-25-003343
Chunk: 730

Company: 60 DEGREES PHARMACEUTICALS, INC.
Filing Date: 2025-03-27
Form: 10-K
Item: Item 1C
Chunk 730
---
0001946563
    
      sxtp:ReverseStockSplitsMember

    2024-07-31
    2024-07-31

    0001946563
    
      sxtp:AmericanPharmaceuticalDistributorMember

    2024-12-31

    0001946563
    
      sxtp:AmericanPharmaceuticalDistributorMember

    2023-12-31

    0001946563
    
      sxtp:USGovernmentAccountedMember

    2023-12-31

    0001946563
    
      sxtp:SignificantCustomersMember
      us-gaap:SalesRevenueNetMember
      us-gaap:CustomerConcentrationRiskMember

    2024-01-01
    2024-12-31

    0001946563
    
      sxtp:SignificantCustomerOneMember
      us-gaap:AccountsReceivableMember
      us-gaap:CustomerConcentrationRiskMember

    2024-01-01
    2024-12-31

    0001946563
    
      sxtp:SignificantCustomerTwoMember
      us-gaap:SalesRevenueNetMember
      us-gaap:CustomerConcentrationRiskMember

    2024-01-01
    2024-12-31

    0001946563
    
      sxtp:SignificantCustomersMember
      us-gaap:AccountsReceivableMember
      us-gaap:CustomerConcentrationRiskMember

    2023-01-01
    2023-12-31

    0001946563
    
      sxtp:CustomerTwoMember
      us-gaap:AccountsReceivableMember
      us-gaap:CustomerConcentrationRiskMember

    2023-01-01
    2023-12-31

    0001946563
    
      sxtp:CustomerThreeMember
      us-gaap:AccountsReceivableMember
      us-gaap:CustomerConcentrationRiskMember

    2023-01-01
    2023-12-31

    0001946563
    
      sxtp:SignificantCustomersMember
      us-gaap:SalesRevenueNetMember
      us-gaap:CustomerConcentrationRiskMember

    2023-01-01
    202